Michele Holcomb
Known title: EVP - Strategy & Corp. Dev.CIK: 0001694167
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cardinal Health Hits Record Highs as Sector Strength Continues. Cardinal Health's stock has reached record highs, outperforming the broader market as the healthcare sector shows strong momentum. In corporate news, Senior Vice President Shane Abeyratne has joined the Customer Experience Advisory Board of Level AI. Meanwhile, market observers are looking ahead to the company's upcoming Q1 2027 earnings report and its position as a defensive option in the current economic environment.
Transaction History
| KE | ▲ Buy | Grant | 4,411 | $125K | 11/14/2025 | View on chart |
| KE | ▲ Buy | Grant | 6,548 | $125K | 11/15/2024 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 9,687 | $672K | 8/15/2022 | View on chart |
| CAH | ▲ Buy | Grant | 13,286 | $0 | 8/9/2022 | View on chart |
| CAH | ▲ Buy | Grant | 8,511 | $0 | 8/15/2021 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 7,739 | $400K | 8/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Cantor Fitzgerald suspends rating on Kimball Electronics
Cantor Fitzgerald has suspended its Overweight rating on Kimball Electronics, removing a key piece of analyst support for the stock. This move comes as the company trades near its 52-week low, with the average analyst target price significantly higher than the current market level. The suspension adds uncertainty to the near-term outlook for investors tracking the stock.
Cantor Fitzgerald suspends rating on Kimball Electronics. Cantor Fitzgerald has suspended its Overweight rating on Kimball Electronics, removing a key piece of analyst support for the stock. This move comes as the company trades near its 52-week low, with the average analyst target price significantly higher than the current market level. The suspension adds uncertainty to the near-term outlook for investors tracking the stock.